# Xeris Biopharma Holdings, Inc.: Executive or director change (Form 8-K, 2026-11-02)

**Trigger Strength Score:** 55/100

| Field | Value |
|---|---|
| Company | Xeris Biopharma Holdings, Inc. |
| Ticker | XERS |
| CIK | 1867096 |
| Filed | 2026-11-02 |
| Event date | 2026-11-02 |
| Primary trigger | Executive or director change |
| All items | 5.02 Executive or director change; 7.01 Regulation FD disclosure |
| Location | Chicago, IL |
| SIC code | 2834 |
| Accession | 0001867096-26-000095 |

## Why this score
- Primary trigger: Executive or director change.
- Filed in the last 3 days.

Source: SEC EDGAR Form 8-K current reports (https://www.sec.gov/Archives/edgar/data/1867096/000186709626000095/xers-20261102.htm). Last refreshed: 2026-11-04T09:16:40.251Z.
Event classification uses the item numbers companies report on Form 8-K; read the filing itself before acting. Informational only; not investment advice and not an offer or solicitation to buy or sell any security.